Pharsight

Drugs that contain Levetiracetam

1. Elepsia Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8535717 TRIPOINT Pharmaceutical composition
Feb, 2026

(2 years from now)

US8425938 TRIPOINT Pharmaceutical composition
Feb, 2026

(2 years from now)

US8163306 TRIPOINT Oral drug delivery system
Sep, 2027

(3 years from now)

US8470367 TRIPOINT Oral drug delivery system
Oct, 2027

(3 years from now)

US8431156 TRIPOINT Pharmaceutical composition
Oct, 2027

(3 years from now)

Market Authorisation Date: 20 December, 2018

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

ELEPSIA XR family patents

Family Patents

2. Keppra patents expiration

KEPPRA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8802142 UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Jun, 2031

(7 years from now)

US8802142

(Pediatric)

UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Dec, 2031

(8 years from now)

Market Authorisation Date: 30 November, 1999

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of KEPPRA before it's drug patent expiration?
More Information on Dosage

KEPPRA family patents

Family Patents

3. Keppra Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7858122 UCB INC Extended release formulation of levetiracetam
Sep, 2028

(4 years from now)

Market Authorisation Date: 12 September, 2008

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of KEPPRA XR before it's drug patent expiration?
More Information on Dosage

KEPPRA XR family patents

Family Patents

4. Spritam patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339489 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam
Mar, 2034

(10 years from now)

US9669009 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam
Mar, 2034

(10 years from now)

US11160786 APRECIA PHARMS Rapid disperse dosage form
Mar, 2034

(10 years from now)

Market Authorisation Date: 31 July, 2015

Treatment: Method of administering levetiracetam; Method of administering levetiracetam under fasted conditions; Method of administering levetiracetam under fed conditions

Dosage: TABLET, FOR SUSPENSION;ORAL

More Information on Dosage

SPRITAM family patents

Family Patents